BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21098033)

  • 1. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.
    Séverin S; Pollitt AY; Navarro-Nuñez L; Nash CA; Mourão-Sá D; Eble JA; Senis YA; Watson SP
    J Biol Chem; 2011 Feb; 286(6):4107-16. PubMed ID: 21098033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
    Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
    Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade.
    Fuller GL; Williams JA; Tomlinson MG; Eble JA; Hanna SL; Pöhlmann S; Suzuki-Inoue K; Ozaki Y; Watson SP; Pearce AC
    J Biol Chem; 2007 Apr; 282(17):12397-409. PubMed ID: 17339324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G
    Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
    J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
    Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
    J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLEC-2 activates Syk through dimerization.
    Hughes CE; Pollitt AY; Mori J; Eble JA; Tomlinson MG; Hartwig JH; O'Callaghan CA; Fütterer K; Watson SP
    Blood; 2010 Apr; 115(14):2947-55. PubMed ID: 20154219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
    Moroi AJ; Watson SP
    J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2).
    Hughes CE; Sinha U; Pandey A; Eble JA; O'Callaghan CA; Watson SP
    J Biol Chem; 2013 Feb; 288(7):5127-35. PubMed ID: 23264619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets.
    Hughes CE; Finney BA; Koentgen F; Lowe KL; Watson SP
    Blood; 2015 Jan; 125(1):144-54. PubMed ID: 25352128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac.
    Pollitt AY; Grygielska B; Leblond B; Désiré L; Eble JA; Watson SP
    Blood; 2010 Apr; 115(14):2938-46. PubMed ID: 20154214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets.
    Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP
    J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
    Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
    J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.
    Rückrich T; Steinle A
    J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.
    Pollitt AY; Poulter NS; Gitz E; Navarro-Nuñez L; Wang YJ; Hughes CE; Thomas SG; Nieswandt B; Douglas MR; Owen DM; Jackson DG; Dustin ML; Watson SP
    J Biol Chem; 2014 Dec; 289(52):35695-710. PubMed ID: 25368330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
    Bhavaraju K; Kim S; Daniel JL; Kunapuli SP
    Eur J Pharmacol; 2008 Feb; 580(3):285-90. PubMed ID: 18068154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.
    Buitrago L; Bhavanasi D; Dangelmaier C; Manne BK; Badolia R; Borgognone A; Tsygankov AY; McKenzie SE; Kunapuli SP
    J Biol Chem; 2013 Oct; 288(40):29160-9. PubMed ID: 23960082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.
    Alshahrani MM; Yang E; Yip J; Ghanem SS; Abdallah SL; deAngelis AM; O'Malley CJ; Moheimani F; Najjar SM; Jackson DE
    Blood; 2014 Oct; 124(15):2431-41. PubMed ID: 25085348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization.
    Lorenz V; Stegner D; Stritt S; Vögtle T; Kiefer F; Witke W; Schymeinsky J; Watson SP; Walzog B; Nieswandt B
    Blood; 2015 Jun; 125(26):4069-77. PubMed ID: 25795918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists.
    Kostyak JC; Mauri BR; Dangelmaier C; Patel A; Zhou Y; Eble JA; Tsygankov AY; McKenzie SE; Kunapuli SP
    TH Open; 2018 Oct; 2(4):e411-e419. PubMed ID: 31249969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.